Efficacy and Safety of Covid-19 Vaccines in Pediatric Patients:  April 13th, 2022 @ 7:30 PM EST

CSACI Webinar

Efficacy and safety of Covid19 vaccine in pediatric patients and approach to adverse reactions in this population

Panelists will address important information about efficacy and safety of Covid19 vaccine in pediatric patients and approach to adverse reactions in this population .  Join us for this important talk and get the latest information on this important topic.  This event is open to CSACI Members only.

Learning Objectives

By the end of the session, learners will be able to:

  1. Outline available evidence for use COVID19 vaccination in the pediatric population, including an update on vaccination studies in children <5 years of age.
  2. Describe common and uncommon adverse reactions to COVID19 vaccination in the pediatric population, including anaphylaxis.
  3. Discuss approach to PEG allergy and anaphylaxis evaluation to COVID19 vaccines in the pediatric population, in particular those with documented allergy to PEG-Asparaginase

“This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Society of Allergy and Clinical Immunology.”

SPEAKERS:

 

julia upton

Julia Upton

Dr. Julia Upton is a Clinical Immunologist and Allergist at the Hospital for Sick Children, an Associate Professor at the University of Toronto, and the Medical Director of the SickKids Clinical Research Center. She is the immediate past Food Allergy and Anaphylaxis Section Head of the Canadian Society of Allergy and Clinical Immunology and on the Health Care Advisory board of Food Allergy Canada. She graduated from Western University Medical school, completed residency at McMaster University, fellowship in Clinical Immunology and Allergy at University of Toronto, and a Master’s in Public Health at the Harvard TH Chan School of Public Health. Her clinical practice focuses on both clinical immunodeficiency and allergy. Her research interests include the identification and care of people with immunodeficiencies and exploring the risk factors, severity, prognosis and treatment of food allergies.

Anne Pham-Huy

Anne Pham-Huy

Dr Anne Pham-Huy completed her medical training at the University of Ottawa in 2003 and her pediatrics and infectious diseases training at McGill University in 2008. She joined CHEO in 2009 as a pediatric infectious diseases specialist and is the physician lead for the CHEO Primary Immunodeficiency Clinic and the program director for the Pediatric Infectious Diseases Training Program. She is a member of the Special Immunization Clinic Network from the Canadian Immunization Research Network (CIRN) and actively sees patients with adverse events following immunizations or relative contraindications to immunization. She is a member of the National Advisory Committee on Immunization (NACI) and current chair for Immunize Canada. Her research interests include patients with inborn errors of immunity and also immunization safety and practices, especially in special populations such as immunocompromised patients and infants exposed to biologics in utero.

Jim Kellner

Jim Kellner

Dr. Jim Kellner is a pediatrician, infectious diseases specialist, vaccine researcher and Professor of Pediatrics at the University of Calgary and Alberta Children’s Hospital. Dr. Kellner was Head of the Department of Pediatrics in Calgary from 2008 to 2018. Since then, he has returned to his academic focus on vaccine preventable infections, including COVID-19, through research and advisory work. He is a member of the federal COVID-19 Immunity Task Force and the Alberta Advisory Committee on Immunization. He is leading and participating in several local, national, and international COVID-19 research studies on immunity in children, vaccine safety and a vaccine clinical trial.  

Moderator: Dr. Victoria Cook

victoria cookDr. Cook grew up in Victoria, and completed a Bachelor of Science degree (Biology) at the University of Victoria in 2006. She then moved to Edmonton where she obtained an MSc in Neuroscience from the University of Alberta in 2008, and remained there to complete her Medical Doctorate in 2012. She completed her Pediatrics Residency at BC Children’s Hospital through the University of British Columbia and remained at UBC and BC Children’s Hospital for her Fellowship training in Pediatric Allergy and Clinical Immunology; completed in June 2017. Her practice and special interests include food allergy, primary immunodeficiency, and auto inflammatory syndromes. She has ongoing research projects with the Division of Allergy at BC Children’s Hospital, and is developing a mobile tool for patients who are concerned about possible food allergy.

For members only